User talk:Bilz0r

It looks like you never got a proper welcome, Bilz0r, and considering your status in various communities, that's surprising! So, even though you've been editing for a while here's my little contribution, the "official" welcome.

Welcome!

Hello, Bilz0r, and welcome to Wikipedia! Thank you for your contributions. I hope you like the place and decide to stay. Here are a few good links for newcomers:

I hope you enjoy editing here and being a Wikipedian! Please sign your name on talk pages using four tildes (~~~~); this will automatically produce your name and the date. If you need help, check out Wikipedia:Where to ask a question, ask me on my talk page, or place {{helpme}} on your talk page and someone will show up shortly to answer your questions. Again, welcome! --Overand 16:12, 26 February 2006 (UTC)[reply]

teleology

Noted your comments on the talk page there, which are on target IMO. I may try to edit it although I don't really know that much about the subject, like you, I dropped in to learn about it. Still, nothing like doing something to help one learn it...Cheers, Kaisershatner 13:22, 20 July 2007 (UTC)[reply]

WikiProject Pharmacology Collaboration of the Week

WikiProject Pharmacology is currently organizing a new Collaboration of the Week program, designed to bring drug and medication related articles up to featured status. We're currently soliciting nominations and/or voting on nominations for the first WP:RxCOTW, to begin on September 5, 2007. Please stop by the Pharmacology Collaboration of the Week page to participate! Thanks! Dr. Cash 17:46, 1 September 2007 (UTC)[reply]

Pharmacology Collaboration of the Week

Aspirin has been selected as this week's Pharmacology Collaboration of the Week! Please help us bring this article up to featured standards during the week. The goal is to nominate this at WP:FAC on September 10, 2007.

Also, please visitWP:RxCOTW to support other articles for the next COTW. Articles that have been nominated thus far include Doxorubicin, Paracetamol (in the lead with 4 support votes so far), Muscle relaxant, Ethanol, and Bufotenin.

In other news:

Bupropion has been promoted to featured status on August 31, 2007.

The Wikipedia:WikiProject Pharmacology main page has been updated and overhauled, to make it easier to find things, as well as to highlight other goals and announcements for the project.

Garrondo is asking for individuals to help review Therapies for multiple sclerosis, as he is considering nominating this article for GA status.

Fvasconcellos notes that discussion is ongoing regarding the current wording of MEDMOS on including dosage information in drug articles. All input is welcome.

Dr. Cash 00:43, 5 September 2007 (UTC)[reply]

WikiProject Pharmacology Update

Here's a brief update in some of the recent developments of WikiProject Pharmacology!

Aspirin has just completed its two week run as the first Collaboration of the Week! Many thanks to those editors that contributed; the article got a lot of good work accomplished, and in particular, much work was done in fixing up the history section. It's still not quite "done" yet (is a wikipedia article really ever done?), but after two weeks I think it's more important to push onwards with the development of the new collaboration of the week program. I will be fixing up Aspirin in the next few days and possibly nominating it for either GA or FA status.

Muscle relaxant has been selected as the new Collaboration of the week until October 2, 2007! This article is currently rated as a "stub", so it's got quite a bit of work cut out for collaborators! Admittedly, featured status could be a long way off,... but still attainable! At the least, maybe we could at least get it up to meeting the Good article criteria? Please stop by the article and help improve it.

Resveratrol, having recently achieved GA status on August 16, 2007, is now making a run for featured status. This is quite a fascinating compound. If you can, please stop by its discussion page and leave comments in support of it.

Please remember that Wikipedia is not a forum for discussing or dispensing medical advice amongst users. Specifically, talk pages of articles should only be used to discuss improving the actual article in question. To help alleviate this situation, the template {{talkheader}} may be added to the top of talk pages, reminding users of the purpose of such pages. Additionally, unsigned comments and comments by anonymous users that are inappropriate may be removed from talk pages without being considered vandalism.

There was an interesting article on ZDNet last week about Hewlett Packard licensing its patented microneedle technology used in common inkjet printers to be used in transdermal patches to deliver a time-controlled release of drugs to patients. This information could be added to articles such as route of administration or drug delivery.

You are receiving this message because you are listed as one of the participants of WikiProject Pharmacology.

Dr. Cash 05:03, 19 September 2007 (UTC)[reply]

your edit to muscle relaxant

I reverted your edit to the article's lead because it did not make sense. First, you started by going into injuries, inflammation and many diseases of the nervous system, instead of defining the main subject, with the title of the article in bold in that sentence (this is actually part of the manual of style). Second, your text only covers the spasmolytics, and doesn't introduce the other of the two major types of muscle relaxant drugs, neuromuscular blockers, so it was incomplete. Dr. Cash 21:47, 19 September 2007 (UTC)[reply]

I am not familiar with Rang Dale and Ritter's Pharmacology books, so I can't verify their content. I am checking two sources on this, both book sources:

Basic & Clinical Pharmacology by Betram G. Katzung (7th Edition, 1998) ISBN 083505651.
Goodman & Gilman's The Pharmacological Basis of Therapeutics (9th Edition, 1996); Eds. Joel G. Hardman & Lee E. Limbird. ISBN 0070262667.

Both sources seem to be in agreement regarding neuromuscular blockers; In the index of Goodman & Gilman's, in fact, I look up 'muscle relaxant' and it says 'see neuromuscular blocking agents'.

Drugs don't necessarily have to have gone through extensive clinical trials to be considered drugs in a particular class - many early drugs developed in the first half of the 20th century, or before, very likely did not go through clinical trials like they do today. Plus, through the natural evolution of things, an early drug is very likely to have been replaced by a newer drug with a slightly different, yet better, mechanism. That's no reason to completely remove that drug from the class entirely.

Furthermore, I don't think the article on muscle relaxants should be comprised primarily of main sections of individual drugs of the whole class. That's going to get way too long, and it won't really help a reader's understanding of what a muscle relaxant does. We need to define the class, and the overall mechanisms of action and pharmacology, and then provide a couple of examples of such agents within the text itself, not as major sections. Dr. Cash 22:55, 19 September 2007 (UTC)[reply]

Hey

Very nice work on Image:Spasticity2.svg. I'd say you can contribute on more than a basic level with vector graphics ;) Fvasconcellos (t·c) 22:00, 23 September 2007 (UTC)[reply]

WikiProject Pharmacology Update

Here are a few updates in the realm of WikiProject Pharmacology:

The Pharmacology Collaboration of the Week has been changed to Collaboration of the Month, based on current participation levels. It is also more likely that articles collaborated on for one month are more likely to achieve featured quality than articles worked on for only a week or two.

The current Collaboration of the Month for November is Receptor antagonist. Please take a look at that article and contribute to it if you get a chance. Ideally, the article should adhere to the featured article criteria.

Therapies for multiple sclerosis is currently a featured article candidate. If you are familiar with the featured article criteria, please visit WP:FAC and review the article.

Anabolic steroid is the wikiproject's newest Featured Article, having been promoted on October 8, 2007.

Theobromine was delisted as a Good Article. The Peer review and GA reassessment discussions provide suggestions on improvement. Muscle relaxant was recently reviewed for Good Article status, but not promoted. Please see the full review full review here for details.

Dr. Cash 22:06, 31 October 2007 (UTC)[reply]

Parafon Forte

Parafon Forte a candidate for the Pharmacology Collaboration of the Month. Please click here to support or comment on the nomination.
You are getting this message as a WikiProject Pharmacology Member

--Cssiitcic (talk) 20:32, 18 November 2008 (UTC)[reply]

Alprazolam is Nominated for GA Status

You are getting this message as a WikiProject Pharmacology member. Cssiitcic (talk) 21:25, 2 February 2009 (UTC)[reply]

Neuroscience

Hello, I noticed that you added the Society for Neuroscience user box to your page, and I just wanted to say, from one electrophysiologist to another, welcome aboard! --Tryptofish (talk) 17:19, 6 April 2010 (UTC)[reply]

The Wikipedia Library now offering accounts from Cochrane Collaboration (sign up!)

The Wikipedia Library (talk | edit)

Get free access to research!

...Support Open Access...

Cochrane Collaboration is an independent medical nonprofit organization consisting of over 28,000 volunteers in more than 100 countries. The collaboration was formed to organize medical scholarship in a systematic way in the interests of evidence-based research: the group conducts systematic reviews of randomized controlled trials of health-care interventions, which it then publishes in the Cochrane Library.

Cochrane has generously agreed to give free, full-access accounts to 100 medical editors. Individual access would otherwise cost between $300 and $800 per account. Thank you Cochrane!

If you are stil active as a medical editor, come and sign up :)

Cheers, Ocaasi^{t | c} 20:02, 16 June 2013 (UTC)[reply]

ArbCom elections are now open!

Hi,
You appear to be eligible to vote in the current Arbitration Committee election. The Arbitration Committee is the panel of editors responsible for conducting the Wikipedia arbitration process. It has the authority to enact binding solutions for disputes between editors, primarily related to serious behavioural issues that the community has been unable to resolve. This includes the ability to impose site bans, topic bans, editing restrictions, and other measures needed to maintain our editing environment. The arbitration policy describes the Committee's roles and responsibilities in greater detail. If you wish to participate, you are welcome to review the candidates' statements and submit your choices on the voting page. For the Election committee, MediaWiki message delivery (talk) 13:07, 23 November 2015 (UTC)[reply]

ArbCom elections are now open!

Hi,
You appear to be eligible to vote in the current Arbitration Committee election. The Arbitration Committee is the panel of editors responsible for conducting the Wikipedia arbitration process. It has the authority to enact binding solutions for disputes between editors, primarily related to serious behavioural issues that the community has been unable to resolve. This includes the ability to impose site bans, topic bans, editing restrictions, and other measures needed to maintain our editing environment. The arbitration policy describes the Committee's roles and responsibilities in greater detail. If you wish to participate, you are welcome to review the candidates' statements and submit your choices on the voting page. For the Election committee, MediaWiki message delivery (talk) 13:32, 23 November 2015 (UTC)[reply]

Need help making a page

Hey! Been trying to make a page for Jeuveau. But it keeps getting deleted. Anyway you can help me start it off? Dgranite (talk) 17:44, 19 January 2020 (UTC)[reply]